Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 10

Results: 29

Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein–Barr virus.

Published in:

2005

By:

Anastasiadou, E.;
Boccellato, F.;
Cirone, M.;
Kis, L. L.;
Klein, E.;
Frati, L.;
Faggioni, A.;
Trivedi, P.

Publication type:

Letter

Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib.

Published in:

2005

By:

Dengler, J.;
von Bubnoff, N.;
Decker, T.;
Peschel, C.;
Duyster, J.

Publication type:

Letter

Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1831, doi. 10.1038/sj.leu.2403885

By:

Tamburini, J.;
Lévy, V.;
Chaleteix, C.;
Fermand, J. P.;
Delmer, A.;
Stalniewicz, L.;
Morel, P.;
Dreyfus, F.;
Grange, M. J.;
Christian, B.;
Choquet, S.;
Leblond, V.

Publication type:

Article

Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1719, doi. 10.1038/sj.leu.2403894

By:

Cammenga, J.

Publication type:

Article

Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children.

Published in:

2005

By:

Lee, S.-Y.;
Kumano, K.;
Masuda, S.;
Hangaishi, A.;
Takita, J.;
Nakazaki, K.;
Kurokawa, M.;
Hayashi, Y.;
Ogawa, S.;
Chiba, S.

Publication type:

Letter

Proteomic analysis of childhood leukemia.

Published in:

2005

By:

Hegedus, C. M.;
Gunn, L.;
Skibola, C. F.;
Zhang, L.;
Shiao, R.;
Fu, S.;
Dalmasso, E. A.;
Metayer, C.;
Dahl, G. V.;
Buffler, P. A.;
Smith, M. T.

Publication type:

journal article

JAK2 Val617Phe activating tyrosine kinase mutation in juvenile myelomonocytic leukemia.

Published in:

2005

By:

Tono, C.;
Xu, G.;
Toki, T.;
Takahashi, Y.;
Sasaki, S.;
Terui, K.;
Ito, E.

Publication type:

Letter

Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1729, doi. 10.1038/sj.leu.2403905

By:

Bruno, B.;
Giaccone, L.;
Rotta, M.;
Anderson, K.;
Boccadoro, M.

Publication type:

Article

Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups.

Published in:

2005

By:

Amadori, S.;
Suciu, S.;
Stasi, R.;
Willemze, R.;
Mandelli, F.;
Selleslag, D.;
Denzlinger, C.;
Muus, P.;
Stauder, R.;
Berneman, Z.;
Pruijt, J.;
Nobile, F.;
Cassibba, V.;
Marie, J.-P.;
Beeldens, F.;
Baila, L.;
Vignetti, M.;
de Witte, T.

Publication type:

journal article

CDK2 catalytic activity and loss of nuclear tethering of retinoblastoma protein in childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1783, doi. 10.1038/sj.leu.2403900

By:

Schmitz, N. M. R.;
Leibundgut, K.;
Hirt, A.

Publication type:

Article

Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1788, doi. 10.1038/sj.leu.2403907

By:

Motta, M.;
Rassenti, L.;
Shelvin, B. J.;
Lerner, S.;
Kipps, T. J.;
Keating, M. J.;
Wierda, W, G,

Publication type:

Article

Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1774, doi. 10.1038/sj.leu.2403898

By:

Burchert, A.;
Wang, Y.;
Cai, D.;
von Bubnoff, N.;
Paschka, P.;
Müller-Brüsselbach, S.;
Ottmann, O. G.;
Duyster, J.;
Hochhaus, A.;
Neubauer, A.

Publication type:

Article

Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1760, doi. 10.1038/sj.leu.2403899

By:

Quentmeier, H.;
Martelli, M. P.;
Dirks, W. G.;
Bolli, N.;
Liso, A.;
MacLeod, R. A. F.;
Nicoletti, I.;
Mannucci, R.;
Pucciarini, A.;
Bigerna, B.;
Martelli, M. F.;
Mecucci, C.;
Drexler, H. G.;
Falini, B.

Publication type:

Article

NK cell subsets and CD107a mobilization assay.

Published in:

2005

By:

Zimmer, J.;
Andrès, E.;
Hentges, F.

Publication type:

Letter

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.

Published in:

2005

By:

Antonioli, E.;
Guglielmelli, P.;
Pancrazzi, A.;
Bogani, C.;
Verrucci, M.;
Ponziani, V.;
Longo, G.;
Bosi, A.;
Vannucchi, A. M.

Publication type:

Letter

Reply to ‘NK cell subsets and CD107a mobilization assay’ by Zimmer et al.

Published in:

2005

By:

Penack, O.;
Gentilini, C.;
Fischer, L.;
Asemissen, A. M.;
Scheibenbogen, C.;
Thiel, E.;
Uharek, L.

Publication type:

Letter

Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1824, doi. 10.1038/sj.leu.2403915

By:

Jardin, F.;
Ruminy, P.;
Parmentier, F.;
Picquenot, J. M.;
Courel, M. N.;
Bertrand, P.;
Buchonnet, G.;
Tilly, H.;
Bastard, C.

Publication type:

Article

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1751, doi. 10.1038/sj.leu.2403910

By:

Bradbury, C. A.;
Khanim, F. L.;
Hayden, R.;
Bunce, C. M.;
White, D. A.;
Drayson, M. T.;
Craddock, C.;
Turner, B. M.

Publication type:

Article

Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death.

Published in:

2005

By:

van der Sluijs-Gelling, A. J.;
van der Velden, V. H. J.;
Roeffen, E. T. J. M.;
Veerman, A. J. P.;
van Wering, E. R.

Publication type:

Letter

Reply to Gaipa et al.

Published in:

2005

By:

van der Sluijs-Gelling, A. J.;
van der Velden, V. H. J.;
Roeffen, E. T. J. M.;
Veerman, A. J. P.;
van Wering, E. R.

Publication type:

Letter

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.

Published in:

2005

By:

Niscola, P;
del Principe, M I;
Maurillo, L;
Venditti, A;
Buccisano, F;
Piccioni, D;
Amadori, S;
del Poeta, G

Publication type:

Letter

Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1818, doi. 10.1038/sj.leu.2403909

By:

Callet-Bauchu, E.;
Baseggio, L.;
Felman, P.;
Traverse-Glehen, A.;
Berger, F.;
Morel, D.;
Gazzo, S.;
Poncet, C.;
Thieblemont, C.;
Coiffier, B.;
Magaud, J. P.;
Salles, G.

Publication type:

Article

Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1812, doi. 10.1038/sj.leu.2403916

By:

Wang, Q.;
Harrison, J. S.;
Uskokovic, M.;
Kutner, A.;
Studzinski, G. P.

Publication type:

Article

Myeloproliferative disorders: the centrosome connection.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1739, doi. 10.1038/sj.leu.2403926

By:

Delaval, B.;
Lelièvre, H.;
Birnbaum, D.

Publication type:

Article

Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P<sub>3</sub>) and lack a PtdIns(3,4,5)P<sub>3</sub> response to cytokines and chemotactic factors; effects reversed by imatinib.

Published in:

2005

By:

Hamzah, H. G.;
Pierce, A.;
Stewart, W. A.;
Downes, C. Peter;
Gray, A.;
Irvine, A.;
Spooncer, E.;
Whetton, A. D.

Publication type:

Letter

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.

Published in:

2005

By:

Gesk, S.;
Gascoyne, R. D.;
Schnitzer, B.;
Bakshi, N.;
Janssen, D.;
Klapper, W.;
Martín-Subero, J. I.;
Parwaresch, R.;
Siebert, R.

Publication type:

Letter

Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1745, doi. 10.1038/sj.leu.2403922

By:

Lehrnbecher, T.;
Bernig, T.;
Hanisch, M.;
Koehl, U.;
Behl, M.;
Reinhardt, D.;
Creutzig, U.;
Klingebiel, T.;
Chanock, S. J.;
Schwabe, D.

Publication type:

Article

Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death.

Published in:

Leukemia (08876924), 2005, v. 19, n. 10, p. 1806, doi. 10.1038/sj.leu.2403923

By:

Tarkanyi, I.;
Dudognon, C.;
Hillion, J;
Pendino, F.;
Lanotte, M.;
Aradi, J.;
Ségal-Bendirdjian, E

Publication type:

Article

Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.

Published in:

2005

By:

Warner, J. K.;
Wang, J. C. Y.;
Takenaka, K.;
Doulatov, S.;
McKenzie, J. L.;
Harrington, L.;
Dick, J. E.

Publication type:

journal article